Algert Global LLC Buys New Stake in Acadia Healthcare Company, Inc. $ACHC

Algert Global LLC purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 92,220 shares of the company's stock, valued at approximately $2,723,000. Algert Global LLC owned approximately 0.10% of Acadia Healthcare as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cibc World Market Inc. bought a new stake in shares of Acadia Healthcare in the second quarter worth about $3,508,000. Bank of Nova Scotia purchased a new position in Acadia Healthcare during the 2nd quarter valued at approximately $14,636,000. Quantbot Technologies LP bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $88,000. Evolve Private Wealth LLC purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $263,000. Finally, Allworth Financial LP purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $45,000.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $28.55 on Friday. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The firm has a market capitalization of $2.66 billion, a price-to-earnings ratio of -2.29, a PEG ratio of 9.73 and a beta of 0.64. The stock's 50-day simple moving average is $30.46 and its 200-day simple moving average is $26.06.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same quarter in the previous year, the firm earned $0.83 EPS. Acadia Healthcare's revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ACHC. UBS Group boosted their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research report on Thursday, July 9th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their target price for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. KeyCorp increased their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a report on Tuesday, July 14th. Raymond James Financial raised Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Friday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source